Lv1
68 积分 2024-06-26 加入
PALB2 and 53BP1 govern post-resection homologous recombination DNA repair
8小时前
待确认
Understanding and overcoming resistance to PARP inhibitors in cancer therapy
1个月前
已完结
PARP inhibitor response in prostate cancer
1个月前
已完结
Cuscuta chinensis Lam.: A systematic review on ethnopharmacology, phytochemistry and pharmacology of an important traditional herbal medicine
2个月前
已完结
The PARP Inhibitor AZD2461 Provides Insights into the Role of PARP3 Inhibition for Both Synthetic Lethality and Tolerability with Chemotherapy in Preclinical Models
2个月前
已完结
Global patterns and trends in breast cancer incidence and mortality across 185 countries
2个月前
已完结
BRCA2 Reversion Mutation Associated With Acquired Resistance to Olaparib in Estrogen Receptor-positive Breast Cancer Detected by Genomic Profiling of Tissue and Liquid Biopsy
3个月前
已完结
Hallmarks of 'BRCAness' in sporadic cancers
3个月前
已完结
Discovery of highly potent PARP7 inhibitors for cancer immunotherapy
3个月前
已完结
Discovery of Highly Selective PARP7 Inhibitors with a Novel Scaffold for Cancer Immunotherapy
3个月前
已完结
皖公网安备34019202002308
